1. Trends Mol Med. 2014 Nov;20(11):614-22. doi: 10.1016/j.molmed.2014.09.001.
Epub  2014 Sep 25.

CDKN1C mutations: two sides of the same coin.

Eggermann T(1), Binder G(2), Brioude F(3), Maher ER(4), Lapunzina P(5), Cubellis 
MV(6), Bergadá I(7), Prawitt D(8), Begemann M(9).

Author information:
(1)Institute of Human Genetics, University Hospital, Technical University 
Aachen, Aachen, Germany. Electronic address: teggermann@ukaachen.de.
(2)University Children's Hospital, Paediatric Endocrinology, University of 
Tübingen, Tübingen, Germany.
(3)AP-HP, Hôpital Armand Trousseau, Explorations Fonctionnelles Endocriniennes, 
Paris, France.
(4)Department of Medical Genetics, University of Cambridge, Cambridge, UK; NIHR 
Cambridge Biomedical Research Centre, Cambridge, UK.
(5)INGEMM, Instituto de Genética Médica y Molecular, Hospital Universitario La 
Paz, IdiPAZ, CIBERER-ISCIII, Madrid, Spain.
(6)Dipartimento di Biologia, Università Federico II, Napoli, Italy.
(7)Centro de Investigaciones Endocrinológicas 'Dr César Bergadá' (CEDIE), 
CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, 
Buenos Aires, Argentina.
(8)Molekulare Pädiatrie, Zentrum für Kinder- und Jugendmedizin, 
Universitätsmedizin Mainz, Mainz, Germany.
(9)Institute of Human Genetics, University Hospital, Technical University 
Aachen, Aachen, Germany.

Cyclin-dependent kinase (CDK)-inhibitor 1C (CDKN1C) negatively regulates 
cellular proliferation and it has been shown that loss-of-function mutations in 
the imprinted CDKN1C gene (11p15.5) are associated with the overgrowth disorder 
Beckwith-Wiedemann syndrome (BWS). With recent reports of gain-of-function 
mutations of the PCNA domain of CDKN1C in growth-retarded patients with IMAGe 
syndrome or Silver-Russell syndrome (SRS), its key role for growth has been 
confirmed. Thereby, the last gap in the spectrum of molecular alterations in 
11p15.5 in growth-retardation and overgrowth syndromes could be closed. Recent 
functional studies explain the strict association of CDKN1C mutations with 
clinically opposite phenotypes and thereby contribute to our understanding of 
the function and regulation of the gene in particular and epigenetic regulation 
in general.

Copyright © 2014 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.molmed.2014.09.001
PMID: 25262539 [Indexed for MEDLINE]